Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

112.52
-1.0000-0.88%
Post-market: 112.520.00000.00%19:49 EST
Volume:951.65K
Turnover:107.15M
Market Cap:6.46B
PE:-72.84
High:114.98
Open:114.37
Low:110.65
Close:113.52
52wk High:161.78
52wk Low:73.16
Shares:57.43M
Float Shares:55.40M
Volume Ratio:1.36
T/O Rate:1.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5448
EPS(LYR):-2.7746
ROE:-12.19%
ROA:-5.74%
PB:8.40
PE(LYR):-40.55

Loading ...

Glaukos assumed with an Outperform at William Blair

TIPRANKS
·
Jan 30

Glaukos Is Maintained at Buy by BTIG

Dow Jones
·
Jan 29

Glaukos price target raised to $131 from $123 at BTIG

TIPRANKS
·
Jan 29

Wells sees potential upside after Glaukos’ iDose repeat dosing label approved

TIPRANKS
·
Jan 28

Glaukos Corp : Btig Raises Target Price to $131 From $123

THOMSON REUTERS
·
Jan 28

BUZZ-U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker International

Reuters
·
Jan 28

Shares of Glaukos Rise 4.2% Premarket After FDA Allows Repeat Use of Glaucoma Implant

THOMSON REUTERS
·
Jan 28

BUZZ-Glaukos rises as FDA allows repeat use of glaucoma implant

Reuters
·
Jan 28

FDA Approves Glaukos Labeling Supplement Allowing iDose TR Re-Administration

Reuters
·
Jan 28

Glaukos Corp - Idose Tr Shows Favorable Long-Term Corneal Safety Profile

THOMSON REUTERS
·
Jan 28

Glaukos Corp - Idose Tr Second Administration Safe and Well-Tolerated

THOMSON REUTERS
·
Jan 28

Glaukos Announces US FDA Approval of Nda Supplement Allowing for Re-Administration of Idose® Tr

THOMSON REUTERS
·
Jan 28

Glaukos (GKOS) Receives a Buy from BTIG

TIPRANKS
·
Jan 27

Stifel Nicolaus Remains a Buy on Glaukos (GKOS)

TIPRANKS
·
Jan 26

Glaukos President and COO Joseph E. Gilliam Reports Disposal of Common Shares

Reuters
·
Jan 24

Glaukos Advances Phase 3 Glaucoma Implant Trial, Keeping GKOS in Focus for Investors

TIPRANKS
·
Jan 22

Glaukos CEO Thomas William Burns Reports Disposal of Common Shares

Reuters
·
Jan 21

Glaukos Corporation to Release Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Jan 20

Stock Track | Glaukos Soars 5.04% Intraday on Wells Fargo's Buy Rating and $122 Price Target

Stock Track
·
Jan 15

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Glaukos (GKOS)

TIPRANKS
·
Jan 15